Rhode Island Quality Institute
Analysis
Rhode Island Quality Institute is a registered charity in United States, based in Providence, RI. It received its IRS tax-exemption ruling in January 2004, 22 years ago. Its declared purposes cover health care, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending December 2023, Rhode Island Quality Institute reported income of $10.0m and spending of $9.9m, spending 99% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $11.0m to $10.0m (-9.3%), an average of -2.4% a year. Over the whole period it spent 93% of the income it received.
Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Rhode Island Quality Institute sits at the 84th percentile: it is larger than about 84% of them. Against every charity in United States with reported income it ranks in the 95th percentile, and in the 94th percentile within RI. Charities of a similar size with the same main cause include Lake Orion Nursing Center Corporation ($10.0m), American Epilepsy Society ($10.0m) and Life Science Cares Inc ($10.0m).
On its Form 990 for the period ending December 2023, revenue came from contributions and grants 10% and program service revenue 90% of the total. Compensation of current officers, directors and key employees was $179k (1.8% of expenses). Other salaries and wages came to $2.8m. At year end it held assets of $8.0m against liabilities of $2.6m, net assets of $5.4m. It reported 33 employees.
Income and spending
Where the income comes from
- Contributions & grants 10%
- Program services 90%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Lake Orion Nursing Center Corporation | Pontiac | $10.0m |
| American Epilepsy Society | Chicago | $10.0m |
| Life Science Cares Inc | Cambridge | $10.0m |
| Medicines360 | San Francisco | $10.0m |